United Therapeutics: Trifecta Of 2026 Tyvaso Franchise Filings Makes It A Compelling Buy

Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?

It could be an attractive contrarian play, but beware of the risks.

H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress

H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress

IT selloff drags Nifty below 24,000; pharma stocks buck the trend

Pharma bucked the broader trend and remained the standout performer of the session. Cipla led gains on the Nifty 50, rising 2.56 per cent to 1,452 with over 37.20 lakh shares traded worth 53,831.39 lakh

AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition

AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition

Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet

Vertex Pharmaceuticals is making its largest acquisition ever, placing a massive 10 billion bet on rare endocrine diseases with the purchase of Crinetics Pharmaceuticals. The deal marks a major strategic shift for the biotechnology leader, which has built its empire around cystic fibrosis treatments but is now expanding aggressively into new high-value therapeutic areas. Under the agreement, Vertex will acquire Crinetics for 85 per share in cash, representing an equity value of approximately 10 billion. The transaction is expected to close in the third quarter of 2026 after receiving customary regulatory approvals. The acquisition gives Vertex access to Crinetics’ growing

20% Off Sephora Promo Code | July 2026

Earn more points on skincare purchases when you use our Sephora coupon.

LIVE PRIMARY Results: The Next DSA Takeover Is In ...

LIVE PRIMARY Results: The Next DSA Takeover Is In ...

Caesars Entertainment (NASDAQ: CZR) Lands on Bear List as Debt Load Overshadows New Property Openings

Caesars Entertainment (NASDAQ: CZR) has been named Zacks Investment Research‘s Bear of the Day amid renewed worry over its balance sheet. The casino operator carries close to 11.9 billion in debt before factoring in billions more in long term lease commitments, according to GamblingNews.uk. Those obligations generate roughly 2.3 billion in annual interest expense according [] The post Caesars Entertainment (NASDAQ: CZR) Lands on Bear List as Debt Load Overshadows New Property Openings appeared first on Foreign Policy Journal.

After Harvey, vertical AI’s next $10B winner might be in agriculture

In legal, Harvey crossed an 11 billion valuation and Legora is racing to claim the European market behind it. In healthcare, Abridge has built a multi-billion-dollar business turning clinical conversations into structured medical records. In customer service, Sierra is now valued at over 15 billion, making it one of the fastest companies in AI history [] This story continues at The Next Web

The Useless Middlemen Making Prescriptions Unaffordable

Pharmacy benefit managers sit at the center of a four-way transaction between patients, insurers, drug manufacturers, and pharmacies. They’ve figured out how to skim profit from every single one of those relationships, explains Senate candidate Abdul El-Sayed.

Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage

Many Americans are shopping around for affordable options as the cost of health insurance soars. But some who hope to keep the same doctors and medications face a thicket of red tape and disruption after they switch plans.

Jersey Mike’s $12 billion IPO filing reveals a $50 million payday for the founder’s stepson and a $41 million jet

Jersey Mike’s has filed for an initial public offering, and its disclosures reveal just how much its founder and former CEO Peter Cancro and his family collected in compensation and other perks. The sandwich chain’s Form S-1 prospectus filed last week shows Cancro’s stepson Phillip Sivolobov received 50.5 million in compensation from the restaurant between []

Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected

Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected

Nasdaq Says SK Hynix Bonanza Opens Path to More Foreign Listings

Nasdaq Inc. President Nelson Griggs said SK Hynix Inc.’s blockbuster listing is spurring other international companies to consider the US for either initial public offerings or the sales of American depositary receipts.

The Empathy Paradox: Why Toxic Managers Are Suddenly Winning the Growth Race

New data reveals a troubling corporate trend—executives who admit to toxic cultures are doubling the financial growth of their empathetic peers. Here’s why.

Police urge caution after health insurance scam steals 80k from someone. Remember, only hand your life savings over and go into medical bankruptcy for actual United Healthcare officials [Murica]

[link] [9 comments]

Comcast’s NBCUniversal Split Could Shake Up Media M&A: Here’s Who Might Be Interested

Comcast co-CEO's Brian Roberts and Mike Cavanagh reiterated that this split isn't about a sale, but Wall Street is already thinking about what comes next.